Jason Silvers
Fortune : 26 240 $ au 31/05/2026
Fortune : 26 240 $ au 31/05/2026
Jason Silvers is currently President & Chief Financial Officer at Generate Biomedicines, Inc., a position starting in 2026.
Formerly, Dr. Silvers was Managing Director at Goldman Sachs & Co. LLC from 2002 to 2022.
Education includes undergraduate studies at Brown University, a doctorate from The Johns Hopkins University School of Medicine, and graduate studies at Yale Law School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/03/2026 | 2 000 ( 0 % ) | 26 240 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| GENERATE BIOMEDICINES, INC. | Directeur Financier/CFO | 01/07/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/06/2022 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale Law School
Yale Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Operates as a clinical-stage generative biology company that provides biotechnology and drug design & development services | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national